Related Experiment Video
Updated: Jan 12, 2026

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
Published on: May 16, 2012
Retraction Note: miR-564 inhibited metastasis and proliferation of prostate cancer by targeting MLLT3
1Laboratory Medicine, Yidu Central Hospital of Weifang City, Weifang, Shandong, China.
Abstract:
The article "miR-564 inhibited metastasis and proliferation of prostate cancer by targeting MLLT3" by F.-J. Meng, F.-M. Meng, H.-X. Wu, X.-F. Cao published in Eur Rev Med Pharmacol Sci 2017; 21 (21): 4828-4834-PMID: 29164580 has been retracted in accordance with the authors, the Publisher, and the Editor in Chief. The authors initially informed the journal of their intention to retract the article due to data inaccuracies and a lack of clarity in some figures. The journal's investigation additionally identified image duplications within the cell migration and invasion assay panels (panels G and H of Figure 3), as well as among the Western blot images (panels E and F of Figure 3). This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/13723.
Insights
This study on prostate cancer has been retracted due to data inaccuracies and figure inconsistencies. The article investigated microRNA-564's role in inhibiting cancer metastasis and proliferation.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Prostate cancer is a leading cause of cancer-related mortality globally.
- MicroRNAs (miRNAs) play crucial roles in cancer development and progression.
- MLLT3 has been implicated in various cancers, including prostate cancer.
Purpose of the Study:
- To investigate the role of microRNA-564 (miR-564) in prostate cancer.
- To determine if miR-564 affects metastasis and proliferation of prostate cancer cells.
- To identify MLLT3 as a potential target of miR-564 in prostate cancer.
Main Methods:
- The study utilized cell lines and molecular biology techniques.
- Methods included assessing cell proliferation, migration, and invasion assays.
- Western blot analysis was performed to evaluate protein expression levels.
Main Results:
- miR-564 was found to inhibit prostate cancer cell metastasis and proliferation.
- MLLT3 was identified as a direct target of miR-564.
- Downregulation of miR-564 was associated with increased MLLT3 expression.
Conclusions:
- miR-564 acts as a tumor suppressor in prostate cancer.
- Targeting MLLT3 by miR-564 offers a potential therapeutic strategy.
- Further research is warranted to explore the clinical applications of miR-564 in prostate cancer treatment.
Related Concept Videos
Abnormal Proliferation
MicroRNAs
MicroRNAs
Mitogens and the Cell Cycle

